Trailing-twelve-month (TTM) revenue is $12.76 Billion with a year-over-year growth of +58.56%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q4 FY2025Period ended 2025-09-27 | $2,096,391,999 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-13 |
| Q1 FY2026Period ended 2025-12-27 | $3,189,693,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-01-26 |
| Q2 FY2026Period ended 2026-03-28 | $4,013,271,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-27 |
| Q3 FY2026Period ended 2026-06-27 | $3,464,016,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-27 |
| TTM revenue | $12,763,371,999 |
Current P/S: $12,275,948,496 market capitalization ÷ $12,763,371,999 TTM revenue = 0.96x.
Market capitalization source: FMP quote. Quote observed 2026-10-02T20:00:00.000Z. Latest revenue period ended 2026-06-27.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q3 FY2026 (2026-06-27): $3.46B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-02T21:05:49.386Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-01.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-09-27 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-09-27 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-10-03 · USD | FY20212021-10-02 · USD | FY20222022-10-01 · USD | FY20232023-09-30 · USD | FY20242024-09-28 · USD | FY20252025-09-27 · USD |
|---|---|---|---|---|---|---|
| CPS Third Party Revenue | $1.3B | $1.3B | $1.5B | $1.7B | $1.5B | $1.6B |
| IMS | N/A | $5.5B | $6.4B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-10-03 · USD | FY20212021-10-02 · USD | FY20222022-10-01 · USD | FY20232023-09-30 · USD | FY20242024-09-28 · USD | FY20252025-09-27 · USD |
|---|---|---|---|---|---|---|
| Americas | $3.5B | $3.2B | $3.7B | $4.4B | $4.0B | $4.7B |
| Asia Pacific | $2.5B | $2.5B | $3.0B | $3.2B |
$12.76B
$12.76 Billion
+58.56%
vs. $8.05B a year ago (TTM)
+12.21%
5 Year compound annual growth rate
1 Year
+58.56%
3 Year
+11.77%
5 Year
+12.21%
10 Year
+7.11%
15 Year
+4.48%
20 Year
+0.68%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $8.13B | +$560.05M | +7.40% |
| 2024 | $7.57B | ($1.37B) | (15.30%) |
| 2023 | $8.94B | +$1.02B | +12.82% |
| 2022 | $7.92B | +$1.18B | +17.53% |
| 2021 | $6.74B | ($211.85M) | (3.05%) |
| 2020 |
TTM Growth
+58.56%
3-Year CAGR
+11.77%
5-Year CAGR
+12.21%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-02T21:05:49.386Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-01.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $6.0B |
| $6.5B |
| IMS Third Party Revenue | $5.7B | N/A | N/A | N/A | N/A | N/A |
|---|
| Other Segments | $1.4B | N/A | N/A | N/A | N/A | N/A |
|---|
| $2.6B |
| EMEA | $996M | $1.1B | $1.2B | $1.3B | $1.0B | $866M |
|---|
| $6.95B |
| ($1.28B) |
| (15.59%) |
| 2019 | $8.23B | +$1.12B | +15.80% |
| 2018 | $7.11B | +$241.51M | +3.52% |
| 2017 | $6.87B | +$387.44M | +5.98% |
| 2016 | $6.48B | +$106.64M | +1.67% |
